Table 1.
Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | |
No of patients screened (≥12 years) | 102 | 108 | 105 | 107 | 118 | 119 | 123 |
No of screened patients ≥18 years (male, female) |
79 (42M, 37F) |
88 (47M, 41F) | 85 (44M, 41F) | 85 (43M, 42F) | 91 (46M, 45F) | 90 (46M, 43F) | 84 (45M, 39F) |
No of screened patients 12–17 years old | 23 (10M, 13F) | 20 (10M, 10F) | 20 (11 M, 9F) | 22 (15M, 7F) | 27 (17M, 10 F) | 30 (21M, 9F) | 39 (25M, 14F) |
% centre female | 49 | 47.2 | 47.6 | 45.8 | 46.6 | 43.6 (peds) | 43 (peds) |
% centre reported ‘white’ | Not provided | 94.5 | 93.5 | 96.5 | 94.5 | 96.1 (peds) | 96.2 (peds) 98.9 (adult) |
% centre F508del homozygous | Not provided | Not provided | Not provided | Not provided | Not provided | 50 (peds) 44.2 (adult) |
48.1% (peds) 49.5 (adult) |
CF, cystic fibrosis; F, female; M, male.